NCT03390504 – A Phase 3 Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Subjects With Advanced Urothelial Cancer and Selected FGFR Gene Aberrations Posted on April 29, 2025 by Molly Willeford -
NCT02277444 – A Multicenter, Open-Label Trial of Intravenous Golimumab, a Human Anti-TNFα Antibody, in Pediatric Subjects With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy Posted on April 29, 2025 by Molly Willeford -
NCT02874742 – Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma Posted on October 28, 2024 by Molly Willeford -
NCT02703272 – A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma Posted on October 28, 2024 by Molly Willeford -
NCT03253796 – Golimumab Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) Posted on October 14, 2024 by Jessica Ritchie -
NCT02365597 – An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer Posted on September 5, 2024 by Molly Willeford -
NCT00367237 – A Randomized, Multicenter, International, Open-label Study of Infliximab Plus Methotrexate Versus Methotrexate (MTX) Alone for the Treatment of MTX naïve Subjects With Active Psoriatic Arthritis Posted on May 15, 2024 by Jessica Ritchie -
NCT00051623 – A Multicenter, Randomized, Double-blind Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab) for the Treatment of Patients With Psoriatic Arthritis Posted on May 9, 2024 by Jessica Ritchie -
NCT03796858 – Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNFα) Therapy Posted on May 9, 2024 by Jessica Ritchie -
The YODA Project